We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.44B
AUM Growth
+$5.13M
Cap. Flow
-$60.9M
Cap. Flow %
-1.77%
Top 10 Hldgs %
13.68%
Holding
1,403
New
134
Increased
468
Reduced
577
Closed
124

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$7.91M
2
SBUX icon
Starbucks
SBUX
+$6.48M
3
CVS icon
CVS Health
CVS
+$6M
4
MDT icon
Medtronic
MDT
+$5.54M
5
WMT icon
Walmart Inc
WMT
+$5.12M

Sector Composition

Rank Sector Weight
1 Healthcare 12.56%
2 Financials 11.38%
3 Technology 10.34%
4 Industrials 9.82%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYK icon
201
Stryker
SYK
$133B
$4.1M 0.12%
34,226
+637
+2% +$73.3K
PE
202
DELISTED
PARSLEY ENERGY INC
PE
$4.09M 0.12%
115,960
-3,020
-3% -$107K
EEM icon
203
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$4.08M 0.12%
116,531
+18,579
+19% +$670K
WP
204
DELISTED
Worldpay, Inc.
WP
$4.07M 0.12%
68,306
+2,373
+4% +$137K
WYNN icon
205
Wynn Resorts
WYNN
$10.5B
$3.97M 0.12%
45,897
+1,486
+3% +$139K
CHKP icon
206
Check Point Software Technologies
CHKP
$13.1B
$3.96M 0.12%
46,908
-362
-0.8% -$29.7K
IJH icon
207
iShares Core S&P Mid-Cap ETF
IJH
$122B
$3.96M 0.12%
119,660
+9,930
+9% +$315K
APC
208
DELISTED
Anadarko Petroleum
APC
$3.95M 0.11%
56,588
-3,335
-6% -$217K
DXJ icon
209
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
$3.93M 0.11%
79,403
-4,690
-6% -$220K
TFC icon
210
Truist Financial
TFC
$63.5B
$3.93M 0.11%
83,633
-1,119
-1% -$47.6K
CNI icon
211
Canadian National Railway
CNI
$76.9B
$3.92M 0.11%
58,121
+47,326
+438% +$3.12M
MGM icon
212
MGM Resorts International
MGM
$11.7B
$3.9M 0.11%
135,321
-16,464
-11% -$456K
LHX icon
213
L3Harris
LHX
$50.7B
$3.88M 0.11%
37,900
-53
-0.1% -$5.24K
NVO
214
Novo Nordisk
NVO
$228B
$3.88M 0.11%
216,156
-84,794
-28% -$1.54M
IWF icon
215
iShares Russell 1000 Growth ETF
IWF
$120B
$3.83M 0.11%
146,196
+55,936
+62% +$1.45M
LVS icon
216
Las Vegas Sands
LVS
$32.3B
$3.83M 0.11%
71,668
+67,280
+1,533% +$3.92M
HUM icon
217
Humana
HUM
$44B
$3.8M 0.11%
18,627
-600
-3% -$114K
ADP icon
218
Automatic Data Processing
ADP
$105B
$3.8M 0.11%
36,959
-627
-2% -$58.5K
UNH icon
219
UnitedHealth
UNH
$383B
$3.76M 0.11%
23,492
-31,667
-57% -$4.73M
LLL
220
DELISTED
L3 Technologies, Inc.
LLL
$3.7M 0.11%
24,352
-999
-4% -$151K
FDN icon
221
First Trust Dow Jones Internet Index Fund ETF
FDN
$5B
$3.7M 0.11%
46,359
+2,542
+6% +$205K
DISCK
222
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$3.67M 0.11%
137,229
+5,219
+4% +$138K
TGT icon
223
Target
TGT
$65.6B
$3.67M 0.11%
50,861
-13,692
-21% -$991K
GSK icon
224
GSK
GSK
$104B
$3.66M 0.11%
76,024
-2,858
-4% -$141K
ELV icon
225
Elevance Health
ELV
$81.6B
$3.65M 0.11%
25,398
-24,544
-49% -$3.29M

Similar funds

Oppenheimer & Co's Q4 2016 Portfolio in Review

As of Q4 2016, Oppenheimer & Co held 1,403 positions worth $3.44B, up 0.15% from $3.43B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co's Q4 2016 filing shows 134 new, 468 increased, 577 reduced and 124 closed positions. Its largest new stake was Yum China: 126,647 shares worth $3.31M. The largest sale was Bank of America, an estimated $7.91M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Technology.

  • Oppenheimer & Co's largest Q4 2016 buy was Yum China: 126,647 shares worth $3.31M.
  • Oppenheimer & Co added most to Lumen in Q4 2016, an estimated $7.38M increase.
  • Oppenheimer & Co's biggest Q4 2016 reduction was Bank of America, cutting an estimated $7.91M.
  • Oppenheimer & Co fully exited iShares MBS ETF in Q4 2016, selling an estimated $3.35M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.44B portfolio in Q4 2016.
  • Oppenheimer & Co opened 134 new positions and closed 124 in Q4 2016.
  • Oppenheimer & Co's portfolio value rose 0.15% quarter-over-quarter to $3.44B.

Based on Oppenheimer & Co's 13F filing for Q4 2016, filed 2 Feb 2017.